DNAnexus
Company

Last deal

$200.M

Amount

Series H

Stage

08.03.2022

Date

9

all rounds

$472.6M

Total amount

General

About Company
DNAnexus accelerates genomic-based health research with a global cloud platform.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2009

Number of employees

Company Type

For Profit

Last funding type

Series H

IPO status

Private

Description

The company provides a biomedical informatics and data management platform that assists researchers in various industries to accelerate their genomics programs globally. DNAnexus combines expertise in cloud computing and bioinformatics to create a secure and scalable platform that enables commercial and academic medical researchers to visualize and analyze big data systems for DNA from a single, unified system. The platform is used by customers around the world to tackle challenging opportunities in human health.
Contacts